nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A1—prostate cancer	0.344	1	CbGaD
Thiabendazole—CYP1A1—Flutamide—prostate cancer	0.126	0.292	CbGbCtD
Thiabendazole—CYP1A1—Estrone—prostate cancer	0.0912	0.211	CbGbCtD
Thiabendazole—CYP1A2—Flutamide—prostate cancer	0.0564	0.13	CbGbCtD
Thiabendazole—CYP1A1—Estradiol—prostate cancer	0.0524	0.121	CbGbCtD
Thiabendazole—CYP1A2—Estrone—prostate cancer	0.0407	0.0943	CbGbCtD
Thiabendazole—CYP1A2—Conjugated Estrogens—prostate cancer	0.0267	0.0617	CbGbCtD
Thiabendazole—CYP1A2—Estradiol—prostate cancer	0.0234	0.0541	CbGbCtD
Thiabendazole—CYP1A2—Etoposide—prostate cancer	0.0153	0.0354	CbGbCtD
Thiabendazole—Lansoprazole—CYP2C18—prostate cancer	0.00129	0.333	CrCbGaD
Thiabendazole—Lansoprazole—CYP1B1—prostate cancer	0.00107	0.275	CrCbGaD
Thiabendazole—Lansoprazole—CYP2C19—prostate cancer	0.000579	0.149	CrCbGaD
Thiabendazole—Lansoprazole—CYP1A1—prostate cancer	0.000577	0.149	CrCbGaD
Thiabendazole—Lansoprazole—CYP3A4—prostate cancer	0.000368	0.0948	CrCbGaD
Thiabendazole—Leukopenia—Mitoxantrone—prostate cancer	0.000202	0.00167	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000202	0.00167	CcSEcCtD
Thiabendazole—Dizziness—Ethinyl Estradiol—prostate cancer	0.0002	0.00165	CcSEcCtD
Thiabendazole—Flushing—Etoposide—prostate cancer	0.0002	0.00165	CcSEcCtD
Thiabendazole—Confusional state—Estradiol—prostate cancer	0.000199	0.00164	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000198	0.00163	CcSEcCtD
Thiabendazole—Anaphylactic shock—Estradiol—prostate cancer	0.000197	0.00163	CcSEcCtD
Thiabendazole—Abdominal pain—Goserelin—prostate cancer	0.000197	0.00163	CcSEcCtD
Thiabendazole—Hyperglycaemia—Capecitabine—prostate cancer	0.000195	0.00161	CcSEcCtD
Thiabendazole—Convulsion—Mitoxantrone—prostate cancer	0.000195	0.00161	CcSEcCtD
Thiabendazole—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000195	0.00161	CcSEcCtD
Thiabendazole—Jaundice—Docetaxel—prostate cancer	0.000194	0.00161	CcSEcCtD
Thiabendazole—Hepatic failure—Epirubicin—prostate cancer	0.000194	0.0016	CcSEcCtD
Thiabendazole—Chills—Etoposide—prostate cancer	0.000193	0.0016	CcSEcCtD
Thiabendazole—Vomiting—Ethinyl Estradiol—prostate cancer	0.000192	0.00159	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000191	0.00158	CcSEcCtD
Thiabendazole—Rash—Ethinyl Estradiol—prostate cancer	0.000191	0.00158	CcSEcCtD
Thiabendazole—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000191	0.00158	CcSEcCtD
Thiabendazole—Headache—Ethinyl Estradiol—prostate cancer	0.00019	0.00157	CcSEcCtD
Thiabendazole—Lymphadenopathy—Doxorubicin—prostate cancer	0.000189	0.00156	CcSEcCtD
Thiabendazole—Jaundice—Capecitabine—prostate cancer	0.000188	0.00155	CcSEcCtD
Thiabendazole—Confusional state—Mitoxantrone—prostate cancer	0.000186	0.00153	CcSEcCtD
Thiabendazole—Haematuria—Capecitabine—prostate cancer	0.000184	0.00152	CcSEcCtD
Thiabendazole—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000184	0.00152	CcSEcCtD
Thiabendazole—Hypersensitivity—Goserelin—prostate cancer	0.000184	0.00152	CcSEcCtD
Thiabendazole—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000182	0.0015	CcSEcCtD
Thiabendazole—Nausea—Ethinyl Estradiol—prostate cancer	0.00018	0.00149	CcSEcCtD
Thiabendazole—Hepatic failure—Doxorubicin—prostate cancer	0.00018	0.00148	CcSEcCtD
Thiabendazole—Asthenia—Goserelin—prostate cancer	0.000179	0.00148	CcSEcCtD
Thiabendazole—Hypoaesthesia—Docetaxel—prostate cancer	0.000178	0.00147	CcSEcCtD
Thiabendazole—Asthenia—Conjugated Estrogens—prostate cancer	0.000177	0.00146	CcSEcCtD
Thiabendazole—Pruritus—Goserelin—prostate cancer	0.000176	0.00146	CcSEcCtD
Thiabendazole—Somnolence—Estradiol—prostate cancer	0.000176	0.00145	CcSEcCtD
Thiabendazole—Anorexia—Mitoxantrone—prostate cancer	0.000175	0.00145	CcSEcCtD
Thiabendazole—Pruritus—Conjugated Estrogens—prostate cancer	0.000175	0.00144	CcSEcCtD
Thiabendazole—Hyperglycaemia—Prednisone—prostate cancer	0.000174	0.00144	CcSEcCtD
Thiabendazole—Dyspepsia—Estradiol—prostate cancer	0.000174	0.00144	CcSEcCtD
Thiabendazole—Visual impairment—Docetaxel—prostate cancer	0.000173	0.00143	CcSEcCtD
Thiabendazole—Hypoaesthesia—Capecitabine—prostate cancer	0.000172	0.00142	CcSEcCtD
Thiabendazole—Hypotension—Mitoxantrone—prostate cancer	0.000172	0.00142	CcSEcCtD
Thiabendazole—Decreased appetite—Estradiol—prostate cancer	0.000172	0.00142	CcSEcCtD
Thiabendazole—Diarrhoea—Goserelin—prostate cancer	0.00017	0.00141	CcSEcCtD
Thiabendazole—Fatigue—Estradiol—prostate cancer	0.00017	0.00141	CcSEcCtD
Thiabendazole—Erythema multiforme—Docetaxel—prostate cancer	0.000169	0.0014	CcSEcCtD
Thiabendazole—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000169	0.00139	CcSEcCtD
Thiabendazole—Leukopenia—Etoposide—prostate cancer	0.000168	0.00139	CcSEcCtD
Thiabendazole—Visual impairment—Capecitabine—prostate cancer	0.000167	0.00138	CcSEcCtD
Thiabendazole—Flushing—Docetaxel—prostate cancer	0.000166	0.00137	CcSEcCtD
Thiabendazole—Dizziness—Goserelin—prostate cancer	0.000165	0.00136	CcSEcCtD
Thiabendazole—Erythema multiforme—Capecitabine—prostate cancer	0.000164	0.00135	CcSEcCtD
Thiabendazole—Somnolence—Mitoxantrone—prostate cancer	0.000164	0.00135	CcSEcCtD
Thiabendazole—Dizziness—Conjugated Estrogens—prostate cancer	0.000163	0.00135	CcSEcCtD
Thiabendazole—Feeling abnormal—Estradiol—prostate cancer	0.000163	0.00134	CcSEcCtD
Thiabendazole—Convulsion—Etoposide—prostate cancer	0.000162	0.00134	CcSEcCtD
Thiabendazole—Dyspepsia—Mitoxantrone—prostate cancer	0.000162	0.00134	CcSEcCtD
Thiabendazole—Tinnitus—Capecitabine—prostate cancer	0.000162	0.00134	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Estradiol—prostate cancer	0.000161	0.00133	CcSEcCtD
Thiabendazole—Flushing—Capecitabine—prostate cancer	0.000161	0.00133	CcSEcCtD
Thiabendazole—Chills—Docetaxel—prostate cancer	0.000161	0.00133	CcSEcCtD
Thiabendazole—Decreased appetite—Mitoxantrone—prostate cancer	0.00016	0.00132	CcSEcCtD
Thiabendazole—Fatigue—Mitoxantrone—prostate cancer	0.000159	0.00131	CcSEcCtD
Thiabendazole—Vomiting—Goserelin—prostate cancer	0.000158	0.00131	CcSEcCtD
Thiabendazole—Rash—Goserelin—prostate cancer	0.000157	0.0013	CcSEcCtD
Thiabendazole—Dermatitis—Goserelin—prostate cancer	0.000157	0.0013	CcSEcCtD
Thiabendazole—Vomiting—Conjugated Estrogens—prostate cancer	0.000157	0.0013	CcSEcCtD
Thiabendazole—Abdominal pain—Estradiol—prostate cancer	0.000156	0.00129	CcSEcCtD
Thiabendazole—Headache—Goserelin—prostate cancer	0.000156	0.00129	CcSEcCtD
Thiabendazole—Rash—Conjugated Estrogens—prostate cancer	0.000156	0.00129	CcSEcCtD
Thiabendazole—Chills—Capecitabine—prostate cancer	0.000156	0.00128	CcSEcCtD
Thiabendazole—Dermatitis—Conjugated Estrogens—prostate cancer	0.000155	0.00128	CcSEcCtD
Thiabendazole—Headache—Conjugated Estrogens—prostate cancer	0.000155	0.00128	CcSEcCtD
Thiabendazole—Confusional state—Etoposide—prostate cancer	0.000154	0.00127	CcSEcCtD
Thiabendazole—Anaphylactic shock—Etoposide—prostate cancer	0.000153	0.00126	CcSEcCtD
Thiabendazole—Feeling abnormal—Mitoxantrone—prostate cancer	0.000152	0.00125	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.00015	0.00124	CcSEcCtD
Thiabendazole—Nausea—Goserelin—prostate cancer	0.000148	0.00122	CcSEcCtD
Thiabendazole—Nausea—Conjugated Estrogens—prostate cancer	0.000147	0.00121	CcSEcCtD
Thiabendazole—Anorexia—Etoposide—prostate cancer	0.000146	0.00121	CcSEcCtD
Thiabendazole—Hypersensitivity—Estradiol—prostate cancer	0.000145	0.0012	CcSEcCtD
Thiabendazole—Abdominal pain—Mitoxantrone—prostate cancer	0.000145	0.0012	CcSEcCtD
Thiabendazole—Flushing—Prednisone—prostate cancer	0.000143	0.00118	CcSEcCtD
Thiabendazole—Hypotension—Etoposide—prostate cancer	0.000143	0.00118	CcSEcCtD
Thiabendazole—Vision blurred—Capecitabine—prostate cancer	0.000142	0.00117	CcSEcCtD
Thiabendazole—Asthenia—Estradiol—prostate cancer	0.000142	0.00117	CcSEcCtD
Thiabendazole—Pruritus—Estradiol—prostate cancer	0.00014	0.00115	CcSEcCtD
Thiabendazole—Leukopenia—Docetaxel—prostate cancer	0.00014	0.00115	CcSEcCtD
Thiabendazole—Hyperglycaemia—Epirubicin—prostate cancer	0.000136	0.00112	CcSEcCtD
Thiabendazole—Somnolence—Etoposide—prostate cancer	0.000136	0.00112	CcSEcCtD
Thiabendazole—Hypersensitivity—Mitoxantrone—prostate cancer	0.000136	0.00112	CcSEcCtD
Thiabendazole—Diarrhoea—Estradiol—prostate cancer	0.000135	0.00112	CcSEcCtD
Thiabendazole—Leukopenia—Capecitabine—prostate cancer	0.000135	0.00112	CcSEcCtD
Thiabendazole—Convulsion—Docetaxel—prostate cancer	0.000135	0.00112	CcSEcCtD
Thiabendazole—Drowsiness—Epirubicin—prostate cancer	0.000135	0.00111	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000133	0.0011	CcSEcCtD
Thiabendazole—Decreased appetite—Etoposide—prostate cancer	0.000133	0.0011	CcSEcCtD
Thiabendazole—Asthenia—Mitoxantrone—prostate cancer	0.000132	0.00109	CcSEcCtD
Thiabendazole—Fatigue—Etoposide—prostate cancer	0.000132	0.00109	CcSEcCtD
Thiabendazole—Jaundice—Epirubicin—prostate cancer	0.000131	0.00108	CcSEcCtD
Thiabendazole—Dizziness—Estradiol—prostate cancer	0.000131	0.00108	CcSEcCtD
Thiabendazole—Haematuria—Epirubicin—prostate cancer	0.000128	0.00106	CcSEcCtD
Thiabendazole—Confusional state—Docetaxel—prostate cancer	0.000128	0.00106	CcSEcCtD
Thiabendazole—Anaphylactic shock—Docetaxel—prostate cancer	0.000127	0.00105	CcSEcCtD
Thiabendazole—Vision blurred—Prednisone—prostate cancer	0.000127	0.00105	CcSEcCtD
Thiabendazole—Feeling abnormal—Etoposide—prostate cancer	0.000126	0.00104	CcSEcCtD
Thiabendazole—Hyperglycaemia—Doxorubicin—prostate cancer	0.000126	0.00104	CcSEcCtD
Thiabendazole—Diarrhoea—Mitoxantrone—prostate cancer	0.000126	0.00104	CcSEcCtD
Thiabendazole—Vomiting—Estradiol—prostate cancer	0.000126	0.00104	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Etoposide—prostate cancer	0.000125	0.00103	CcSEcCtD
Thiabendazole—Rash—Estradiol—prostate cancer	0.000125	0.00103	CcSEcCtD
Thiabendazole—Drowsiness—Doxorubicin—prostate cancer	0.000124	0.00103	CcSEcCtD
Thiabendazole—Dermatitis—Estradiol—prostate cancer	0.000124	0.00103	CcSEcCtD
Thiabendazole—Confusional state—Capecitabine—prostate cancer	0.000124	0.00103	CcSEcCtD
Thiabendazole—Headache—Estradiol—prostate cancer	0.000124	0.00102	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000123	0.00102	CcSEcCtD
Thiabendazole—Angioedema—Prednisone—prostate cancer	0.000123	0.00101	CcSEcCtD
Thiabendazole—Jaundice—Doxorubicin—prostate cancer	0.000121	0.001	CcSEcCtD
Thiabendazole—Anorexia—Docetaxel—prostate cancer	0.000121	0.001	CcSEcCtD
Thiabendazole—Abdominal pain—Etoposide—prostate cancer	0.000121	0.000999	CcSEcCtD
Thiabendazole—Hypoaesthesia—Epirubicin—prostate cancer	0.00012	0.000993	CcSEcCtD
Thiabendazole—Hypotension—Docetaxel—prostate cancer	0.000119	0.000982	CcSEcCtD
Thiabendazole—Haematuria—Doxorubicin—prostate cancer	0.000119	0.00098	CcSEcCtD
Thiabendazole—Anorexia—Capecitabine—prostate cancer	0.000117	0.00097	CcSEcCtD
Thiabendazole—Nausea—Estradiol—prostate cancer	0.000117	0.000969	CcSEcCtD
Thiabendazole—Vomiting—Mitoxantrone—prostate cancer	0.000117	0.000966	CcSEcCtD
Thiabendazole—Convulsion—Prednisone—prostate cancer	0.000116	0.000962	CcSEcCtD
Thiabendazole—Visual impairment—Epirubicin—prostate cancer	0.000116	0.000961	CcSEcCtD
Thiabendazole—Rash—Mitoxantrone—prostate cancer	0.000116	0.000958	CcSEcCtD
Thiabendazole—Dermatitis—Mitoxantrone—prostate cancer	0.000116	0.000957	CcSEcCtD
Thiabendazole—Headache—Mitoxantrone—prostate cancer	0.000115	0.000952	CcSEcCtD
Thiabendazole—Hypotension—Capecitabine—prostate cancer	0.000115	0.000951	CcSEcCtD
Thiabendazole—Erythema multiforme—Epirubicin—prostate cancer	0.000114	0.000943	CcSEcCtD
Thiabendazole—Somnolence—Docetaxel—prostate cancer	0.000113	0.000934	CcSEcCtD
Thiabendazole—Hypersensitivity—Etoposide—prostate cancer	0.000113	0.000932	CcSEcCtD
Thiabendazole—Tinnitus—Epirubicin—prostate cancer	0.000113	0.00093	CcSEcCtD
Thiabendazole—Flushing—Epirubicin—prostate cancer	0.000112	0.000926	CcSEcCtD
Thiabendazole—Dyspepsia—Docetaxel—prostate cancer	0.000112	0.000925	CcSEcCtD
Thiabendazole—Hypoaesthesia—Doxorubicin—prostate cancer	0.000111	0.000918	CcSEcCtD
Thiabendazole—Decreased appetite—Docetaxel—prostate cancer	0.000111	0.000913	CcSEcCtD
Thiabendazole—Asthenia—Etoposide—prostate cancer	0.00011	0.000907	CcSEcCtD
Thiabendazole—Anaphylactic shock—Prednisone—prostate cancer	0.00011	0.000906	CcSEcCtD
Thiabendazole—Fatigue—Docetaxel—prostate cancer	0.00011	0.000906	CcSEcCtD
Thiabendazole—Nausea—Mitoxantrone—prostate cancer	0.000109	0.000903	CcSEcCtD
Thiabendazole—Dyspepsia—Capecitabine—prostate cancer	0.000108	0.000895	CcSEcCtD
Thiabendazole—Chills—Epirubicin—prostate cancer	0.000108	0.000895	CcSEcCtD
Thiabendazole—Pruritus—Etoposide—prostate cancer	0.000108	0.000895	CcSEcCtD
Thiabendazole—Visual impairment—Doxorubicin—prostate cancer	0.000108	0.000889	CcSEcCtD
Thiabendazole—Decreased appetite—Capecitabine—prostate cancer	0.000107	0.000884	CcSEcCtD
Thiabendazole—Fatigue—Capecitabine—prostate cancer	0.000106	0.000877	CcSEcCtD
Thiabendazole—Erythema multiforme—Doxorubicin—prostate cancer	0.000106	0.000873	CcSEcCtD
Thiabendazole—Feeling abnormal—Docetaxel—prostate cancer	0.000105	0.000866	CcSEcCtD
Thiabendazole—Diarrhoea—Etoposide—prostate cancer	0.000105	0.000865	CcSEcCtD
Thiabendazole—Anorexia—Prednisone—prostate cancer	0.000105	0.000864	CcSEcCtD
Thiabendazole—Tinnitus—Doxorubicin—prostate cancer	0.000104	0.000861	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Docetaxel—prostate cancer	0.000104	0.000859	CcSEcCtD
Thiabendazole—Flushing—Doxorubicin—prostate cancer	0.000104	0.000857	CcSEcCtD
Thiabendazole—Feeling abnormal—Capecitabine—prostate cancer	0.000101	0.000838	CcSEcCtD
Thiabendazole—Dizziness—Etoposide—prostate cancer	0.000101	0.000836	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Capecitabine—prostate cancer	0.000101	0.000832	CcSEcCtD
Thiabendazole—Abdominal pain—Docetaxel—prostate cancer	0.000101	0.000831	CcSEcCtD
Thiabendazole—Chills—Doxorubicin—prostate cancer	0.0001	0.000828	CcSEcCtD
Thiabendazole—Vision blurred—Epirubicin—prostate cancer	9.91e-05	0.000818	CcSEcCtD
Thiabendazole—Abdominal pain—Capecitabine—prostate cancer	9.74e-05	0.000804	CcSEcCtD
Thiabendazole—Vomiting—Etoposide—prostate cancer	9.73e-05	0.000804	CcSEcCtD
Thiabendazole—Dyspepsia—Prednisone—prostate cancer	9.66e-05	0.000798	CcSEcCtD
Thiabendazole—Rash—Etoposide—prostate cancer	9.65e-05	0.000797	CcSEcCtD
Thiabendazole—Dermatitis—Etoposide—prostate cancer	9.64e-05	0.000796	CcSEcCtD
Thiabendazole—Headache—Etoposide—prostate cancer	9.59e-05	0.000792	CcSEcCtD
Thiabendazole—Decreased appetite—Prednisone—prostate cancer	9.54e-05	0.000788	CcSEcCtD
Thiabendazole—Fatigue—Prednisone—prostate cancer	9.46e-05	0.000781	CcSEcCtD
Thiabendazole—Leukopenia—Epirubicin—prostate cancer	9.41e-05	0.000777	CcSEcCtD
Thiabendazole—Hypersensitivity—Docetaxel—prostate cancer	9.37e-05	0.000774	CcSEcCtD
Thiabendazole—Vision blurred—Doxorubicin—prostate cancer	9.17e-05	0.000757	CcSEcCtD
Thiabendazole—Asthenia—Docetaxel—prostate cancer	9.13e-05	0.000754	CcSEcCtD
Thiabendazole—Convulsion—Epirubicin—prostate cancer	9.11e-05	0.000752	CcSEcCtD
Thiabendazole—Nausea—Etoposide—prostate cancer	9.09e-05	0.000751	CcSEcCtD
Thiabendazole—Hypersensitivity—Capecitabine—prostate cancer	9.07e-05	0.00075	CcSEcCtD
Thiabendazole—Feeling abnormal—Prednisone—prostate cancer	9.04e-05	0.000747	CcSEcCtD
Thiabendazole—Pruritus—Docetaxel—prostate cancer	9e-05	0.000743	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Prednisone—prostate cancer	8.97e-05	0.000741	CcSEcCtD
Thiabendazole—Asthenia—Capecitabine—prostate cancer	8.84e-05	0.00073	CcSEcCtD
Thiabendazole—Pruritus—Capecitabine—prostate cancer	8.71e-05	0.00072	CcSEcCtD
Thiabendazole—Leukopenia—Doxorubicin—prostate cancer	8.71e-05	0.000719	CcSEcCtD
Thiabendazole—Diarrhoea—Docetaxel—prostate cancer	8.7e-05	0.000719	CcSEcCtD
Thiabendazole—Abdominal pain—Prednisone—prostate cancer	8.67e-05	0.000716	CcSEcCtD
Thiabendazole—Confusional state—Epirubicin—prostate cancer	8.65e-05	0.000715	CcSEcCtD
Thiabendazole—Anaphylactic shock—Epirubicin—prostate cancer	8.58e-05	0.000709	CcSEcCtD
Thiabendazole—Convulsion—Doxorubicin—prostate cancer	8.43e-05	0.000696	CcSEcCtD
Thiabendazole—Diarrhoea—Capecitabine—prostate cancer	8.43e-05	0.000696	CcSEcCtD
Thiabendazole—Dizziness—Docetaxel—prostate cancer	8.41e-05	0.000695	CcSEcCtD
Thiabendazole—Anorexia—Epirubicin—prostate cancer	8.18e-05	0.000676	CcSEcCtD
Thiabendazole—Dizziness—Capecitabine—prostate cancer	8.14e-05	0.000673	CcSEcCtD
Thiabendazole—Vomiting—Docetaxel—prostate cancer	8.09e-05	0.000668	CcSEcCtD
Thiabendazole—Hypersensitivity—Prednisone—prostate cancer	8.08e-05	0.000668	CcSEcCtD
Thiabendazole—Rash—Docetaxel—prostate cancer	8.02e-05	0.000663	CcSEcCtD
Thiabendazole—Hypotension—Epirubicin—prostate cancer	8.02e-05	0.000662	CcSEcCtD
Thiabendazole—Dermatitis—Docetaxel—prostate cancer	8.01e-05	0.000662	CcSEcCtD
Thiabendazole—Confusional state—Doxorubicin—prostate cancer	8e-05	0.000661	CcSEcCtD
Thiabendazole—Headache—Docetaxel—prostate cancer	7.97e-05	0.000658	CcSEcCtD
Thiabendazole—Anaphylactic shock—Doxorubicin—prostate cancer	7.94e-05	0.000656	CcSEcCtD
Thiabendazole—Asthenia—Prednisone—prostate cancer	7.87e-05	0.00065	CcSEcCtD
Thiabendazole—Vomiting—Capecitabine—prostate cancer	7.83e-05	0.000647	CcSEcCtD
Thiabendazole—Rash—Capecitabine—prostate cancer	7.76e-05	0.000641	CcSEcCtD
Thiabendazole—Pruritus—Prednisone—prostate cancer	7.76e-05	0.000641	CcSEcCtD
Thiabendazole—Dermatitis—Capecitabine—prostate cancer	7.76e-05	0.000641	CcSEcCtD
Thiabendazole—Headache—Capecitabine—prostate cancer	7.71e-05	0.000637	CcSEcCtD
Thiabendazole—Somnolence—Epirubicin—prostate cancer	7.63e-05	0.00063	CcSEcCtD
Thiabendazole—Anorexia—Doxorubicin—prostate cancer	7.57e-05	0.000625	CcSEcCtD
Thiabendazole—Nausea—Docetaxel—prostate cancer	7.56e-05	0.000624	CcSEcCtD
Thiabendazole—Dyspepsia—Epirubicin—prostate cancer	7.55e-05	0.000624	CcSEcCtD
Thiabendazole—Diarrhoea—Prednisone—prostate cancer	7.51e-05	0.00062	CcSEcCtD
Thiabendazole—Decreased appetite—Epirubicin—prostate cancer	7.46e-05	0.000616	CcSEcCtD
Thiabendazole—Hypotension—Doxorubicin—prostate cancer	7.42e-05	0.000613	CcSEcCtD
Thiabendazole—Fatigue—Epirubicin—prostate cancer	7.4e-05	0.000611	CcSEcCtD
Thiabendazole—Nausea—Capecitabine—prostate cancer	7.32e-05	0.000604	CcSEcCtD
Thiabendazole—Dizziness—Prednisone—prostate cancer	7.25e-05	0.000599	CcSEcCtD
Thiabendazole—Feeling abnormal—Epirubicin—prostate cancer	7.07e-05	0.000584	CcSEcCtD
Thiabendazole—Somnolence—Doxorubicin—prostate cancer	7.06e-05	0.000583	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Epirubicin—prostate cancer	7.02e-05	0.00058	CcSEcCtD
Thiabendazole—Dyspepsia—Doxorubicin—prostate cancer	6.99e-05	0.000577	CcSEcCtD
Thiabendazole—Vomiting—Prednisone—prostate cancer	6.97e-05	0.000576	CcSEcCtD
Thiabendazole—Rash—Prednisone—prostate cancer	6.92e-05	0.000571	CcSEcCtD
Thiabendazole—Dermatitis—Prednisone—prostate cancer	6.91e-05	0.000571	CcSEcCtD
Thiabendazole—Decreased appetite—Doxorubicin—prostate cancer	6.9e-05	0.00057	CcSEcCtD
Thiabendazole—Headache—Prednisone—prostate cancer	6.87e-05	0.000568	CcSEcCtD
Thiabendazole—Fatigue—Doxorubicin—prostate cancer	6.84e-05	0.000565	CcSEcCtD
Thiabendazole—Abdominal pain—Epirubicin—prostate cancer	6.78e-05	0.00056	CcSEcCtD
Thiabendazole—Feeling abnormal—Doxorubicin—prostate cancer	6.54e-05	0.00054	CcSEcCtD
Thiabendazole—Nausea—Prednisone—prostate cancer	6.52e-05	0.000538	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Doxorubicin—prostate cancer	6.49e-05	0.000536	CcSEcCtD
Thiabendazole—Hypersensitivity—Epirubicin—prostate cancer	6.32e-05	0.000522	CcSEcCtD
Thiabendazole—Abdominal pain—Doxorubicin—prostate cancer	6.28e-05	0.000518	CcSEcCtD
Thiabendazole—Asthenia—Epirubicin—prostate cancer	6.16e-05	0.000508	CcSEcCtD
Thiabendazole—Pruritus—Epirubicin—prostate cancer	6.07e-05	0.000501	CcSEcCtD
Thiabendazole—Diarrhoea—Epirubicin—prostate cancer	5.87e-05	0.000485	CcSEcCtD
Thiabendazole—Hypersensitivity—Doxorubicin—prostate cancer	5.85e-05	0.000483	CcSEcCtD
Thiabendazole—Asthenia—Doxorubicin—prostate cancer	5.7e-05	0.00047	CcSEcCtD
Thiabendazole—Dizziness—Epirubicin—prostate cancer	5.67e-05	0.000469	CcSEcCtD
Thiabendazole—Pruritus—Doxorubicin—prostate cancer	5.62e-05	0.000464	CcSEcCtD
Thiabendazole—Vomiting—Epirubicin—prostate cancer	5.45e-05	0.000451	CcSEcCtD
Thiabendazole—Diarrhoea—Doxorubicin—prostate cancer	5.43e-05	0.000449	CcSEcCtD
Thiabendazole—Rash—Epirubicin—prostate cancer	5.41e-05	0.000447	CcSEcCtD
Thiabendazole—Dermatitis—Epirubicin—prostate cancer	5.4e-05	0.000446	CcSEcCtD
Thiabendazole—Headache—Epirubicin—prostate cancer	5.37e-05	0.000444	CcSEcCtD
Thiabendazole—Dizziness—Doxorubicin—prostate cancer	5.25e-05	0.000434	CcSEcCtD
Thiabendazole—Nausea—Epirubicin—prostate cancer	5.1e-05	0.000421	CcSEcCtD
Thiabendazole—Vomiting—Doxorubicin—prostate cancer	5.05e-05	0.000417	CcSEcCtD
Thiabendazole—Rash—Doxorubicin—prostate cancer	5.01e-05	0.000413	CcSEcCtD
Thiabendazole—Dermatitis—Doxorubicin—prostate cancer	5e-05	0.000413	CcSEcCtD
Thiabendazole—Headache—Doxorubicin—prostate cancer	4.97e-05	0.000411	CcSEcCtD
Thiabendazole—Nausea—Doxorubicin—prostate cancer	4.72e-05	0.00039	CcSEcCtD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	3.15e-05	0.000319	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	3.14e-05	0.000317	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTM1—prostate cancer	3.07e-05	0.000311	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP3A43—prostate cancer	3.04e-05	0.000308	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AMACR—prostate cancer	3.04e-05	0.000308	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SRD5A2—prostate cancer	3.04e-05	0.000308	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—DEGS1—prostate cancer	3.04e-05	0.000308	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NAT1—prostate cancer	3.04e-05	0.000308	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTM1—prostate cancer	3.03e-05	0.000306	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	2.99e-05	0.000303	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	2.97e-05	0.000301	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP1A1—prostate cancer	2.91e-05	0.000294	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSD17B1—prostate cancer	2.9e-05	0.000294	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	2.9e-05	0.000294	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HAO1—prostate cancer	2.87e-05	0.000291	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP1A1—prostate cancer	2.87e-05	0.00029	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	2.79e-05	0.000282	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	2.78e-05	0.000281	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	2.75e-05	0.000278	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	2.68e-05	0.000271	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	2.62e-05	0.000265	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—B4GALT4—prostate cancer	2.59e-05	0.000262	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HPGD—prostate cancer	2.59e-05	0.000262	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	2.57e-05	0.00026	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	2.47e-05	0.00025	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TNFRSF21—prostate cancer	2.43e-05	0.000246	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	2.39e-05	0.000242	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTAP—prostate cancer	2.37e-05	0.000239	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP7B1—prostate cancer	2.37e-05	0.000239	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PSAT1—prostate cancer	2.34e-05	0.000237	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TST—prostate cancer	2.34e-05	0.000237	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GRHL1—prostate cancer	2.34e-05	0.000237	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CBR1—prostate cancer	2.34e-05	0.000237	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADI1—prostate cancer	2.34e-05	0.000237	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CSAD—prostate cancer	2.34e-05	0.000237	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.31e-05	0.000234	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SRD5A1—prostate cancer	2.31e-05	0.000233	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SULT1E1—prostate cancer	2.31e-05	0.000233	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	2.29e-05	0.000232	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	2.24e-05	0.000227	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.24e-05	0.000227	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.21e-05	0.000223	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSD17B3—prostate cancer	2.2e-05	0.000223	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ACSL4—prostate cancer	2.2e-05	0.000223	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—prostate cancer	2.18e-05	0.00022	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CKMT2—prostate cancer	2.18e-05	0.00022	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GRHPR—prostate cancer	2.18e-05	0.00022	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—UGT2B17—prostate cancer	2.18e-05	0.00022	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—UGT2B15—prostate cancer	2.18e-05	0.00022	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.17e-05	0.00022	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	2.13e-05	0.000215	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PHGDH—prostate cancer	2.11e-05	0.000213	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—UMPS—prostate cancer	2.11e-05	0.000213	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ARG2—prostate cancer	2.11e-05	0.000213	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.1e-05	0.000212	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—MED12—prostate cancer	2.09e-05	0.000212	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LDHB—prostate cancer	2.07e-05	0.000209	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PGAM2—prostate cancer	2.05e-05	0.000207	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AOX1—prostate cancer	2.05e-05	0.000207	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NAGLU—prostate cancer	2.05e-05	0.000207	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTM3—prostate cancer	2.05e-05	0.000207	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SULT2B1—prostate cancer	2.05e-05	0.000207	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MBTPS1—prostate cancer	2.05e-05	0.000207	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—RFK—prostate cancer	2.05e-05	0.000207	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP3A5—prostate cancer	2.03e-05	0.000205	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	2e-05	0.000202	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PDHA1—prostate cancer	1.96e-05	0.000198	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TCN2—prostate cancer	1.96e-05	0.000198	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—UCP3—prostate cancer	1.96e-05	0.000198	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA3—prostate cancer	1.96e-05	0.000198	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AMACR—prostate cancer	1.94e-05	0.000196	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP3A43—prostate cancer	1.94e-05	0.000196	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—DEGS1—prostate cancer	1.94e-05	0.000196	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SRD5A2—prostate cancer	1.94e-05	0.000196	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NAT1—prostate cancer	1.94e-05	0.000196	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.91e-05	0.000193	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.9e-05	0.000192	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSD3B1—prostate cancer	1.87e-05	0.000189	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC22A3—prostate cancer	1.87e-05	0.000189	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSD17B1—prostate cancer	1.85e-05	0.000187	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.85e-05	0.000187	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.81e-05	0.000184	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TBXAS1—prostate cancer	1.79e-05	0.000181	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA4—prostate cancer	1.79e-05	0.000181	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.78e-05	0.00018	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.77e-05	0.000179	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.75e-05	0.000177	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA2—prostate cancer	1.75e-05	0.000177	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCG5—prostate cancer	1.73e-05	0.000175	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SULT1A1—prostate cancer	1.73e-05	0.000175	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA1—prostate cancer	1.69e-05	0.000171	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.67e-05	0.000169	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTO1—prostate cancer	1.67e-05	0.000169	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NAT2—prostate cancer	1.67e-05	0.000169	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSD3B2—prostate cancer	1.67e-05	0.000169	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—B4GALT4—prostate cancer	1.65e-05	0.000167	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HPGD—prostate cancer	1.65e-05	0.000167	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.6e-05	0.000162	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2C18—prostate cancer	1.6e-05	0.000162	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLCB2—prostate cancer	1.6e-05	0.000162	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LRP2—prostate cancer	1.6e-05	0.000162	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—P4HB—prostate cancer	1.57e-05	0.000159	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TNFRSF21—prostate cancer	1.55e-05	0.000157	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC22A1—prostate cancer	1.52e-05	0.000154	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP7B1—prostate cancer	1.51e-05	0.000153	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTAP—prostate cancer	1.51e-05	0.000153	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.51e-05	0.000153	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SULT2A1—prostate cancer	1.49e-05	0.00015	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.47e-05	0.000149	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SULT1E1—prostate cancer	1.47e-05	0.000149	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SRD5A1—prostate cancer	1.47e-05	0.000149	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MED12—prostate cancer	1.46e-05	0.000148	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GNG5—prostate cancer	1.45e-05	0.000147	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.43e-05	0.000145	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.41e-05	0.000142	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSD17B3—prostate cancer	1.4e-05	0.000142	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ACSL4—prostate cancer	1.4e-05	0.000142	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOA3—prostate cancer	1.4e-05	0.000141	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.39e-05	0.00014	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.37e-05	0.000139	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PHGDH—prostate cancer	1.34e-05	0.000136	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ARG2—prostate cancer	1.34e-05	0.000136	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—UMPS—prostate cancer	1.34e-05	0.000136	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.34e-05	0.000135	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HPGDS—prostate cancer	1.33e-05	0.000135	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2C19—prostate cancer	1.32e-05	0.000134	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LDHB—prostate cancer	1.32e-05	0.000133	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP3A5—prostate cancer	1.29e-05	0.000131	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTT1—prostate cancer	1.29e-05	0.000131	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ACHE—prostate cancer	1.29e-05	0.000131	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2A6—prostate cancer	1.28e-05	0.000129	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.27e-05	0.000129	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PDHA1—prostate cancer	1.25e-05	0.000126	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA3—prostate cancer	1.25e-05	0.000126	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—UCP3—prostate cancer	1.25e-05	0.000126	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TCN2—prostate cancer	1.25e-05	0.000126	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKR1C3—prostate cancer	1.24e-05	0.000126	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PRKACB—prostate cancer	1.24e-05	0.000125	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP17A1—prostate cancer	1.22e-05	0.000124	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.21e-05	0.000122	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSD3B1—prostate cancer	1.19e-05	0.000121	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC22A3—prostate cancer	1.19e-05	0.000121	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOA2—prostate cancer	1.17e-05	0.000118	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.16e-05	0.000117	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA4—prostate cancer	1.14e-05	0.000116	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TBXAS1—prostate cancer	1.14e-05	0.000116	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.12e-05	0.000113	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA2—prostate cancer	1.11e-05	0.000113	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC5A5—prostate cancer	1.11e-05	0.000113	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCG5—prostate cancer	1.1e-05	0.000111	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SULT1A1—prostate cancer	1.1e-05	0.000111	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2E1—prostate cancer	1.09e-05	0.00011	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA1—prostate cancer	1.08e-05	0.000109	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NQO1—prostate cancer	1.07e-05	0.000109	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSD3B2—prostate cancer	1.06e-05	0.000108	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTO1—prostate cancer	1.06e-05	0.000108	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NAT2—prostate cancer	1.06e-05	0.000108	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TH—prostate cancer	1.06e-05	0.000107	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.05e-05	0.000106	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP3A4—prostate cancer	1.05e-05	0.000106	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.04e-05	0.000105	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP1B1—prostate cancer	1.03e-05	0.000104	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.02e-05	0.000103	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLCB2—prostate cancer	1.02e-05	0.000103	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2C18—prostate cancer	1.02e-05	0.000103	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LRP2—prostate cancer	1.02e-05	0.000103	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—P4HB—prostate cancer	9.99e-06	0.000101	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GGT1—prostate cancer	9.97e-06	0.000101	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOA1—prostate cancer	9.83e-06	9.94e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC22A1—prostate cancer	9.72e-06	9.84e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP19A1—prostate cancer	9.68e-06	9.8e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	9.61e-06	9.72e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SULT2A1—prostate cancer	9.47e-06	9.59e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—RXRA—prostate cancer	9.35e-06	9.46e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MED12—prostate cancer	9.32e-06	9.43e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GNG5—prostate cancer	9.25e-06	9.36e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.09e-06	9.2e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—COMT—prostate cancer	9e-06	9.11e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTP1—prostate cancer	8.96e-06	9.07e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOA3—prostate cancer	8.91e-06	9.01e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ITPR1—prostate cancer	8.82e-06	8.92e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	8.75e-06	8.86e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.67e-06	8.77e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HPGDS—prostate cancer	8.5e-06	8.6e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2C19—prostate cancer	8.44e-06	8.54e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TYMS—prostate cancer	8.33e-06	8.43e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTT1—prostate cancer	8.24e-06	8.34e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ACHE—prostate cancer	8.24e-06	8.34e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTM1—prostate cancer	8.23e-06	8.33e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2A6—prostate cancer	8.15e-06	8.24e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	8.12e-06	8.21e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LPL—prostate cancer	8.08e-06	8.18e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKR1C3—prostate cancer	7.93e-06	8.02e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PRKACB—prostate cancer	7.88e-06	7.98e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP17A1—prostate cancer	7.8e-06	7.89e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ERCC2—prostate cancer	7.74e-06	7.83e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.7e-06	7.79e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOA2—prostate cancer	7.43e-06	7.52e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTHFR—prostate cancer	7.28e-06	7.36e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARA—prostate cancer	7.14e-06	7.22e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC5A5—prostate cancer	7.09e-06	7.18e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2E1—prostate cancer	6.93e-06	7.01e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NQO1—prostate cancer	6.85e-06	6.93e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TH—prostate cancer	6.75e-06	6.83e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CAV1—prostate cancer	6.71e-06	6.79e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.71e-06	6.79e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP3A4—prostate cancer	6.68e-06	6.76e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.65e-06	6.72e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP1B1—prostate cancer	6.57e-06	6.65e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.41e-06	6.49e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GGT1—prostate cancer	6.36e-06	6.44e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOA1—prostate cancer	6.26e-06	6.34e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP19A1—prostate cancer	6.17e-06	6.25e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CG—prostate cancer	6.11e-06	6.19e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—RXRA—prostate cancer	5.96e-06	6.03e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.8e-06	5.86e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—INS—prostate cancer	5.79e-06	5.86e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—COMT—prostate cancer	5.74e-06	5.81e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTP1—prostate cancer	5.71e-06	5.78e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CREBBP—prostate cancer	5.67e-06	5.74e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ITPR1—prostate cancer	5.62e-06	5.69e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.53e-06	5.59e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CD—prostate cancer	5.37e-06	5.44e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TYMS—prostate cancer	5.31e-06	5.37e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTM1—prostate cancer	5.25e-06	5.31e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LPL—prostate cancer	5.15e-06	5.21e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NOS3—prostate cancer	5.08e-06	5.14e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP1A1—prostate cancer	4.98e-06	5.04e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ERCC2—prostate cancer	4.94e-06	4.99e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CB—prostate cancer	4.68e-06	4.74e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS2—prostate cancer	4.64e-06	4.7e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTHFR—prostate cancer	4.64e-06	4.69e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARA—prostate cancer	4.55e-06	4.61e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CAV1—prostate cancer	4.28e-06	4.33e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.09e-06	4.14e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTEN—prostate cancer	4.05e-06	4.1e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CG—prostate cancer	3.9e-06	3.94e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—EP300—prostate cancer	3.86e-06	3.91e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—INS—prostate cancer	3.69e-06	3.73e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CREBBP—prostate cancer	3.61e-06	3.66e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CD—prostate cancer	3.43e-06	3.47e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NOS3—prostate cancer	3.24e-06	3.27e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CB—prostate cancer	2.99e-06	3.02e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS2—prostate cancer	2.96e-06	2.99e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CA—prostate cancer	2.86e-06	2.89e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTEN—prostate cancer	2.58e-06	2.61e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—EP300—prostate cancer	2.46e-06	2.49e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKT1—prostate cancer	2.33e-06	2.36e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.82e-06	1.84e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKT1—prostate cancer	1.49e-06	1.51e-05	CbGpPWpGaD
